House Erbitux Probe Widens To Firms That Considered ImClone Partnership

The House Energy & Commerce Committee is widening its Erbitux investigation to include several companies who considered partnering with ImClone on the colorectal cancer drug

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet